Skip to main content

Table 2 Details in controlled ovarian hyper-stimulation (COH) and oocyte retrieval in IVF

From: Confrontment and solution to gonadotropin resistance and low oocyte retrieval in in vitro fertilization for type I BPES: a case series with review of literature

 

AFC

PFC

OR

FORT

ORR

Total Gn dose (IU)

Gn/day (IU)

COH days

Gn/Weight (IU/kg)

Ovulation triggering medication /ovulation triggering-to-harvest interval

Patient 1 Cycle 1 (at 32yo) a

N/A

6

0

N/A

0

N/A

N/A

N/A

N/A

N/A / 36hours

Patient 1 Cycle 2 (at 32yo)

12

2

1

0.16

0.50

4050

368

11

73

GnRH agonist 0.1mg+rhCG 250mcg / 40hours

Patient 2 Cycle 1 (at32yo)

13

7

1

0.54

0.14

9600c

457

21

147

GnRH agonist 0.1mg+rhCG 250mcg / 36hours

Patient 2 Cycle 2 (at 32yo)

7

7

3

1.00

0.42

8850c

491

18

136

GnRH agonist 0.1mg+rhCG 250mcg / 36hours

Controls b

8.2

6.5

6.8

0.91

1.03

2362

254

9.4

43

Varied

  1. AFC Antral follicle count, PFC Preovulatory follicle count, number of follicles ≥14mm at triggering day, OR Number of oocytes retrieved, FORT Follicular output rate = PFC/AFC ×100%, ORR Oocyte retrieval rate = number of OR/PFC ×100%, Gn Gonadotropin
  2. a Patient 1 cycle 1 was done at another centre, and therefore some clinical data was not available
  3. bAveraged data from our IVF centre, calculated from all cycles done in the same year for same-aged patients
  4. cClomiphene citrate was used simultaneously